FDG-PET is useful in staging and follow-up of primary uterine cervical lymphoma

Clinical Nuclear Medicine

Volumn 32, Issue 9, 2007, Pages 748-750

  Bural, Gonca G ^a   Shriaknthan, Sankaran ^a   Houseni, Mohamed ^a   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

FDG PET; Follow up; Primary cervical uterine lymphoma; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DRUG UPTAKE; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; PAPANICOLAOU TEST; PELVIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; TUMOR BIOPSY; UTERINE CERVIX; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VAGINA BLEEDING;

ADULT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; NEOPLASM STAGING; RADIOPHARMACEUTICALS; UTERINE CERVICAL NEOPLASMS;

EID: 34548101926     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318124fd89     Document Type: Article

References (25)

1. Suzuki Y, Tamaki Y, Hasegawa M, et al. Magnetic resonance images of primary malignant lymphoma of the uterine body: a case report. Jpn J Clin Oncol. 2000;11:519-521.
2. Grace A, O'Connell N, Byrne P, et al. Malignant lymphoma of the cervix. An unusual presentation and a rare disease. Eur J Gynaecol Oncol. 1999;20:26-28.
3. Marin C, Seoane JM, Sanchez M, et al. Magnetic resonance imaging of primary lymphoma of the cervix. Eur Radiol. 2002;12:1541-1545.
4. Miketic LM, Carroll R, Harris NL, et al. Computed tomography in the evaluation of lymphoma of the uterine cervix. J Comput Tomogr. 1988;12:154-158.
5. Szantho A, Balega J, Csapo Z, et al. Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report. Gynecol Oncol. 2003;89:171-174.
6. Van Renterghem N, De Paepe P, Van den Broecke R, et al. Primary lymphoma of the cervix uteri: a diagnostic challenge. Report of two cases and review of the literature. Eur J Gynaecol Oncol. 2005;26:36-38.
7. Harris NL, Scully RE. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer. 1984;53:2530-2545.
8. Kuo HC, Chou CY, Chang CH, et al. Primary malignant lymphoma of the uterine cervix shows favorable response to neoadjuvant chemotherapy. Gynecol Oncol. 1994;52:408-410.
9. Clarke DP, Ostler P, Watkinson A, et al. Case report: magnetic resonance imaging in primary cervical lymphoma: the role in diagnosis and follow-up. Clin Radiol. 1998;53:383-385.
10. Vang R, Medeiros LJ, Ha CS, et al. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol. 2000;13:19-28.
11. Muntz HG, Ferry JA, Flynn D, et al. Stage IE primary malignant lymphomas of the uterine cervix. Cancer. 1991;68:2023-2032.
12. Komaki R, Cox JD, Hansen RM, et al. Malignant lymphoma of the uterine cervix. Cancer. 1984;54:1699-1704.
13. Aozasa K, Saeki K, Ohsawa M, et al. Malignant lymphoma of the uterus. Report of seven cases with immunohistochemical study. Cancer. 1993;72:195919-195964.
14. Pomares Arias E, Payeras Mas M, et al. Diffuse T-cell lymphoma of the cervix uteri: an unusual localization of an infrequent tumor. An Med Interna. 2000;17:432-433.
15. al-Talib RK, Sworn MJ, Ramsay AD, et al. Primary cervical lymphoma: the role of cervical cytology. Cytopathology. 1996;7:173-177.
16. Garavaglia E, Taccagni G, Montoli S, et al. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients. Gynecol Oncol. 2005;97:214-218.
17. Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imag. 2005;32:549-556.
18. Zhu Z, Wang B, Cheng W, et al. Endometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation. Clin Nucl Med. 2006;31:781-787.
19. Chander S, Meltzer CC, McCook BM. Physiologic uterine uptake of FDG during menstruation demonstrated with serial combined positron emission tomography and computed tomography. Clin Nucl Med. 2002;27:22-24.
20. Lin E. FDG PET appearance of a postpartum uterus. Clin Nucl Med. 2006;31:159-160.
21. Kao CH. FDG uptake in a huge uterine myoma. Clin Nucl Med. 2003;28:249.
22. Hope AJ, Saha P, Grigsby PW, et al. FDG-PET in carcinoma of the uterine cervix with endometrial extension. Cancer. 2006;106:196-200.
23. Yen TC, See LC, Lai CH, et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med. 2004;45:22-29.
24. Umesaki N, Tanaka T, Miyama M, et al. Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-D-glucose in the diagnosis of uterine leiomyosarcoma: a case report. Clin Imag. 2001;25:203-205.
25. Nakahara T, Fujii H, Ide M, et al. F-18 FDG uptake in endometrial cancer. Clin Nucl Med. 2001;26:82-83.